Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,651 | -23,425 | -17,891 | -11,288 | -4,065 |
| Depreciation Amortization | 203 | 800 | 560 | 102 | 146 |
| Accounts receivable | 31 | N/A | 61 | 60 | 47 |
| Accounts payable and accrued liabilities | 88 | -341 | -239 | 11 | -406 |
| Other Working Capital | 564 | -747 | -860 | -158 | -1,312 |
| Other Operating Activity | 846 | 3,388 | 2,240 | 849 | 205 |
| Operating Cash Flow | $-4,919 | $-20,325 | $-16,129 | $-10,424 | $-5,385 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,086 | -9,990 | -16,041 | 5,858 | -1,121 |
| PPE Investments | N/A | -38 | -38 | -23 | -2 |
| Other Investing Activity | 0 | 1,165 | 1,165 | 1,165 | 1,000 |
| Investing Cash Flow | $5,086 | $-8,863 | $-14,914 | $7,000 | $-123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 23,782 | 23,837 | 398 | 396 |
| Financing Cash Flow | $N/A | $23,782 | $23,837 | $398 | $396 |
| Beginning Cash Position | 10,127 | 15,533 | 15,533 | 15,533 | 15,533 |
| End Cash Position | 10,294 | 10,127 | 8,327 | 12,507 | 10,421 |
| Net Cash Flow | $167 | $-5,406 | $-7,206 | $-3,026 | $-5,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,919 | -20,325 | -16,129 | -10,424 | -5,385 |
| Capital Expenditure | N/A | -38 | -38 | -23 | -2 |
| Free Cash Flow | -4,919 | -20,363 | -16,167 | -10,447 | -5,387 |